Bill Maughan
Stock Analyst at Clear Street
(0)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CRSP CRISPR Therapeutics | Downgrades: Hold | 45 | 47.45 | -5.16% | 1 | Jun 27, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Buy | 26 26 | 4.74 | 448.52% | 2 | Aug 13, 2024 | |
NKTX Nkarta | Maintains: Buy | 16 15 | 1.67 | 798.2% | 2 | May 10, 2024 | |
FATE Fate Therapeutics | Maintains: Buy | 11 9 | 1.03 | 773.79% | 1 | May 10, 2024 | |
IMCR Immunocore Hldgs | Maintains: Hold | 63 67 | 31.15 | 115.09% | 3 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 91 106 | 27.17 | 290.14% | 3 | May 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 24 | 0.53 | 4428.3% | 1 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 | 7.23 | 729.88% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 52.94 | -15% | 1 | Nov 2, 2023 |